At a glance
- Originator Cornell University
- Class Antineoplastics; Lactones
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 07 Aug 1998 Investigation in Cancer in USA (Unknown route)
- 16 May 1996 Preclinical development for Cancer in USA (Unknown route)